Free Trial
TSE:ONC

Oncolytics Biotech (ONC) Stock Price, News & Analysis

Oncolytics Biotech logo
C$14.90 -0.20 (-1.32%)
As of 09/3/2025

About Oncolytics Biotech Stock (TSE:ONC)

Key Stats

Today's Range
C$14.90
C$14.90
50-Day Range
C$1.17
C$18.60
52-Week Range
C$0.44
C$2.08
Volume
280 shs
Average Volume
169,589 shs
Market Capitalization
C$1.50 billion
P/E Ratio
N/A
Dividend Yield
0.31%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONC Stock News Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
Oncolytics Biotech (ONCY) Gets a Buy from Lake Street
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

Oncolytics Biotech's stock was trading at C$1.33 at the beginning of the year. Since then, ONC stock has increased by 1,020.3% and is now trading at C$14.90.

Oncolytics Biotech Inc. (TSE:ONC) released its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.01.

Shares of ONC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncolytics Biotech investors own include Oncolytics Biotech (ONCY), Ballard Power Systems (BLDP), (ONCYF) (ONCYF), Resverlogix (RVX), Birchcliff Energy (BIR), Enbridge (ENB) and

Company Calendar

Last Earnings
11/12/2024
Today
10/06/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:ONC
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$27.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.94%
Return on Assets
-71.33%

Debt

Debt-to-Equity Ratio
11.75
Current Ratio
2.99
Quick Ratio
8.86

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$3.53 per share
Price / Cash Flow
4.22
Book Value
C$0.12 per share
Price / Book
126.70

Miscellaneous

Outstanding Shares
100,361,000
Free Float
N/A
Market Cap
C$1.50 billion
Optionable
Not Optionable
Beta
0.80
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (TSE:ONC) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners